Kintor Pharmaceutical Limited (KNTPF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 869.23 Million CNY | -57.7% |
| 2022 | 2.05 Billion CNY | -0.62% |
| 2021 | 2.06 Billion CNY | 11.69% |
| 2020 | 1.85 Billion CNY | 234.58% |
| 2019 | 553.37 Million CNY | 30.64% |
| 2018 | 423.59 Million CNY | 762.09% |
| 2017 | 49.13 Million CNY | 189.89% |
| 2016 | 16.94 Million CNY | -57.75% |
| 2015 | 40.11 Million CNY | 198.35% |
| 2014 | 13.44 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 739.54 Million CNY | -14.92% |
| 2024 Q2 | 739.54 Million CNY | 0.0% |
| 2023 Q2 | 1.87 Billion CNY | 0.0% |
| 2023 FY | 869.23 Million CNY | -57.7% |
| 2023 Q1 | 1.87 Billion CNY | -8.81% |
| 2023 Q4 | 869.23 Million CNY | 0.0% |
| 2023 Q3 | 869.23 Million CNY | -53.62% |
| 2022 Q2 | 1.75 Billion CNY | 0.0% |
| 2022 Q4 | 2.05 Billion CNY | 0.0% |
| 2022 Q1 | 1.75 Billion CNY | -15.36% |
| 2022 FY | 2.05 Billion CNY | -0.62% |
| 2022 Q3 | 2.05 Billion CNY | 17.41% |
| 2021 Q1 | 2.4 Billion CNY | 29.68% |
| 2021 FY | 2.06 Billion CNY | 11.69% |
| 2021 Q4 | 2.06 Billion CNY | 0.0% |
| 2021 Q3 | 2.06 Billion CNY | -13.87% |
| 2021 Q2 | 2.4 Billion CNY | 0.0% |
| 2020 Q3 | 1.85 Billion CNY | -14.96% |
| 2020 FY | 1.85 Billion CNY | 234.58% |
| 2020 Q1 | 2.17 Billion CNY | 293.43% |
| 2020 Q2 | 2.17 Billion CNY | 0.0% |
| 2020 Q4 | 1.85 Billion CNY | 0.0% |
| 2019 Q4 | 553.37 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 553.37 Million CNY | 30.64% |
| 2019 Q3 | 553.37 Million CNY | 0.0% |
| 2018 FY | 423.59 Million CNY | 762.09% |
| 2017 Q3 | 49.13 Million CNY | 10.69% |
| 2017 FY | 49.13 Million CNY | 189.89% |
| 2017 Q1 | 44.38 Million CNY | 161.89% |
| 2017 Q2 | 44.38 Million CNY | 0.0% |
| 2017 Q4 | 49.13 Million CNY | 0.0% |
| 2016 Q4 | 16.94 Million CNY | 0.0% |
| 2016 FY | 16.94 Million CNY | -57.75% |
| 2016 Q1 | 37.47 Million CNY | 0.0% |
| 2016 Q3 | 16.94 Million CNY | 0.0% |
| 2015 FY | 40.11 Million CNY | 198.35% |
| 2014 FY | 13.44 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -37628990.909% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -567.558% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -112692.937% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -157335.34% |
| Qrons Inc. | 420.00 USD | -206959900.0% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -245711.712% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -8136.043% |
| BioStem Technologies, Inc. | 14.56 Million USD | -5869.881% |
| Skye Bioscience, Inc. | 11.94 Million USD | -7179.749% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -180780.104% |
| Rebus Holdings, Inc. | 5000.00 USD | -17384540.0% |
| CSL Limited | 38.02 Billion USD | 97.714% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -3010.621% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -1549.365% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -126336.32% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -44289.587% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -2137.578% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -11939.621% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1138323.658% |
| SQZ Biotechnologies Company | 107.18 Million USD | -710.949% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -60599.202% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1201077.365% |
| Mesoblast Limited | 667.9 Million USD | -30.144% |
| Marizyme, Inc. | 22.01 Million USD | -3848.349% |
| Genus plc | 1.02 Billion USD | 15.518% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -63891.613% |
| Pharming Group N.V. | 462.85 Million USD | -87.798% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -26136.911% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -174081.176% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -138533.493% |
| ContraFect Corporation | 20.67 Million USD | -4103.453% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -222571.032% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -227342.258% |
| IMV Inc. | 31.33 Million USD | -2674.105% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -20865.446% |
| MultiCell Technologies, Inc. | 126.22 USD | -688664137.046% |
| ONE Bio Corp. | 70.08 Million USD | -1140.245% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -92402.094% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -576.392% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -201244.409% |
| Q BioMed Inc. | 3.51 Million USD | -24625.581% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -2370.883% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -332586.0% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1177417.983% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -94.76% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -59894.906% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -2795.997% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -31550.618% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -33290.955% |
| GB Sciences, Inc. | 103.44 Thousand USD | -840208.579% |
| Alpha Cognition Inc. | 2.45 Million USD | -35347.461% |
| HST Global, Inc. | 1526.00 USD | -56961367.89% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -87881.886% |
| Halberd Corporation | 10.13 Thousand USD | -8579823.009% |
| Enzolytics Inc. | 361.7 Million USD | -140.314% |
| Agentix Corp. | 261.39 Thousand USD | -332439.634% |
| Resverlogix Corp. | 8.11 Million USD | -10611.423% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -46187.942% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 80.864% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -1722.213% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -135790.541% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -3815500.72% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -9613.006% |
| AVAX Technologies, Inc. | 7.37 Million USD | -11682.75% |
| Zenith Capital Corp. | 7410.00 USD | -11730426.316% |
| Genscript Biotech Corporation | 3.38 Billion USD | 74.332% |
| Ember Therapeutics, Inc. | 184.00 USD | -472408595.652% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -270010.564% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -332475.259% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -93571.178% |
| Kadimastem Ltd | 2.3 Million USD | -37625.773% |
| Helix BioMedix, Inc. | 3.02 Million USD | -28634.125% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -1522357.701% |
| LadRx Corporation | 2.3 Million USD | -37563.624% |
| Cell Source, Inc. | 195.17 Thousand USD | -445269.445% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -245711.712% |
| NovAccess Global Inc. | 62.24 Thousand USD | -1396301.491% |
| Affymax, Inc. | 7.44 Million USD | -11578.517% |
| Itoco Inc. | 1.4 Million USD | -61984.807% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -908596.698% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -819930.189% |
| Mobile Lads Corp. | 52.00 USD | -1671599900.0% |
| CytoDyn Inc. | 11.13 Million USD | -7705.603% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -607873.589% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -4861376.51% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -225398.676% |
| SYBLEU INC | 330.46 Thousand USD | -262930.611% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -212207.106% |
| International Stem Cell Corporation | 5.39 Million USD | -16026.753% |
| Bioxytran, Inc. | 137.63 Thousand USD | -631434.896% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -5694.173% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -5142.97% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -1100193.671% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -100426.786% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -11463.549% |
| Neutra Corp. | 2851.00 USD | -30488570.642% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -2582.318% |
| PureTech Health plc | 693.97 Million USD | -25.254% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -10669.699% |
| IXICO plc | 15.84 Million USD | -5386.224% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -10395.436% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -741.268% |
| CSL Limited | 38.02 Billion USD | 97.714% |
| Cellectis S.A. | 333.99 Million USD | -160.253% |